GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pluri Inc (XTAE:PLUR) » Definitions » Price-to-Funds-From-Operations

Pluri (XTAE:PLUR) Price-to-Funds-From-Operations : (As of Apr. 16, 2025)


View and export this data going back to 2010. Start your Free Trial

What is Pluri Price-to-Funds-From-Operations?

Price-to-Funds-From-Operations only applies to REITs.


Pluri Business Description

Industry
Traded in Other Exchanges
Address
MATAM Advanced Technology Park, Building No.5, Haifa, ISR, 3508409
Pluri Inc is a biotechnology company, that creates cell-based products for commercial use and is pioneering a biotech revolution that promotes wellbeing and sustainability. The company's technology platform developed a three-dimensional, or 3D, technology platform for cell expansion with an industrial scale in-house Good Manufacturing Practice, or GMP, cell manufacturing facility. It uses its technology in the field of regenerative medicine, food tech and agricultural technology or agtech.